首页> 外文期刊>Human psychopharmacology: clinical and experimental >Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs.
【24h】

Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs.

机译:银杏Triple-blind,安慰剂对照试验biloba导致性功能障碍抗抑郁药物。

获取原文
获取原文并翻译 | 示例
           

摘要

A triple-blind (investigator, patient, statistician), randomized, placebo-controlled, trial of Ginkgo biloba 240 mg daily was carried out. Following a 1-week control, it was given to 24 patients with sexual impairment due to antidepressant drugs. Efficacy analysis was carried out on eight males and five females on placebo and six males and five females on Ginkgo, completing the full 12 weeks of treatment. Not included were three subjects who dropped out after 6 weeks. A validated, sex (gender)-orientated questionnaire was recorded at - 1, 0, 1, 3, 6, 9 and 12 weeks, and a non-blind follow-up for a further 6-weeks on Ginkgo. Hamilton anxiety and depression ratings were made at 0, 6 and 12 weeks and simple global assessments of alertness and memory. There were some spectacular individual responses in both groups, but no statistically significant differences, and no differences in side-effects.
机译:triple-blind(研究员、耐心统计学家)、随机、安慰剂对照,银杏叶240毫克每日进行审判出去了。24性损伤患者由于抗抑郁药物。进行八个男人和五个女人银杏安慰剂和六个男人和五个女人,完成完整的12周的治疗。包括三个受试者退出6周之后。(性别)面向问卷被记录- 1, 0, 1、3、6、9和12周,非盲后续进一步对银杏6周。汉密尔顿焦虑和抑郁评分在0、6和12周和简单的全球评估的警觉性和记忆。一些壮观的个人反应在两种组,但无统计学意义差异,没有副作用的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号